Criterios de terapia anti coagulante en pacientes con fibrilaciòn auricular

Atrial fibrillation is a common cardiac arrhythmia in clinical practice, its diagnosis in most cases is because it debuted with a cerebrovascular accident, hence its importance due to the increase in morbidity and mortality, and it is necessary to obtain a primary detection from primary health care. early on of this disease and with the consequent anticoagulation treatment, although the AVK anticoagulants have been widely used and for many years, recent studies show an underutilization or misuse, scales have emerged to stratify the thromboembolic risk and based on that the anticoagulant therapy in intermediate and high risks, in turn the anticoagulated patients will be applied a hemorrhagic risk algorithm allowing us to identify the modifiable risk factors and change them to have an optimal treatment, due to the instability of the Warfarin molecule and complications of maintain an adequate INR Once the NACO emerges with promising effectiveness.